Insight Molecular Diagnostics Inc. Common Stock IMDX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$47.84M+17.8% | -$50.22M+17.2% | -$60.78M-40.9% | -$63.42M-75.5% | -$58.21M-45.7% | ||
| $2.34M+41.9% | $2.19M+48.4% | $2.17M+75.1% | $1.9M+43.7% | $1.65M+13.2% | ||
| $2.36M+30.6% | $2.22M+26.6% | $2M+14.9% | $1.93M+1.6% | $1.81M-22.9% | ||
| -$23.98M-5.7% | -$22.18M-7.2% | -$21.99M-11.3% | -$23.02M-27.9% | -$22.7M-20.4% | ||
| $3.49M+337% | $3.19M+517% | $1.92M+239% | $957K— | $799K— | ||
| -$3.49M-339% | -$3.19M-522% | -$1.92M— | -$953K— | -$795K— | ||
| —— | —— | —— | —— | $49.24M— | ||
| —— | —— | —— | —— | —— | ||
| -$27.48M-16.9% | -$25.37M-19.6% | -$23.91M-17.6% | -$23.98M— | -$23.5M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Insight Molecular Diagnostics Inc. Common Stock generate?
- Insight Molecular Diagnostics Inc. Common Stock (IMDX) generated -$24.0M in operating cash flow over the trailing twelve months.
- What is Insight Molecular Diagnostics Inc. Common Stock's free cash flow?
- After $3.5M of capital expenditures, Insight Molecular Diagnostics Inc. Common Stock's free cash flow was -$27.5M over the trailing twelve months, down 16.9% year over year.
- Where does Insight Molecular Diagnostics Inc. Common Stock's cash flow data come from?
- Every line is extracted from Insight Molecular Diagnostics Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
